Eli Lilly misses on earnings but raises full-year guidance
The company reported adjusted earnings of $1.62, which missed analyst expectations of $1.73 for the quarter.
The company reported adjusted earnings of $1.62, which missed analyst expectations of $1.73 for the quarter.
What's Your Reaction?
